Cargando…

Cardiovascular efficacy of sitagliptin in patients with diabetes at high risk of cardiovascular disease: a 12-month follow-up

BACKGROUND: Gliptins should have beneficial effects beyond glycemic control, potentially on the pathophysiology of cardiovascular (CV) diseases, with some basic studies demonstrating this possibility. However, we are yet to answer whether there are any direct CV effects in the clinical setting. We a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakamura, Takashi, Iwanaga, Yoshitaka, Miyaji, Yuki, Nohara, Ryuji, Ishimura, Takao, Miyazaki, Shunichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818390/ https://www.ncbi.nlm.nih.gov/pubmed/27036865 http://dx.doi.org/10.1186/s12933-016-0371-z

Ejemplares similares

Renocardiovascular Biomarkers: from the Perspective of Managing Chronic Kidney Disease and Cardiovascular Disease
por: Niizuma, Shinichiro, et al.
Publicado: (2017)

Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysis
por: Engel, Samuel S, et al.
Publicado: (2013)

Risk stratification for major adverse cardiac events and ventricular tachyarrhythmias by cardiac MRI in patients with cardiac sarcoidosis
por: Yasuda, Masakazu, et al.
Publicado: (2016)

Sitagliptin does not reduce the risk of cardiovascular death or hospitalization for heart failure following myocardial infarction in patients with diabetes: observations from TECOS
por: Nauck, Michael A., et al.
Publicado: (2019)

Re‐adjudication of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) with study‐level meta‐analysis of hospitalization for heart failure from cardiovascular outcomes trials with dipeptidyl peptidase‐4 (DPP‐4) inhibitors
por: Scirica, Benjamin M., et al.
Publicado: (2022)

Combination of coronary CT angiography, FFR(CT), and risk factors in the prediction of major adverse cardiovascular events in patients suspected CAD
por: Wada, Shinichi, et al.
Publicado: (2023)

Cardiac Magnetic Resonance Identified the Fibrotic Lesion Associated with Syncope Attack Due to Complete Atrioventricular Block in a Patient with Hypertrophic Cardiomyopathy and Aortic Stenosis
por: Kawamura, Takayuki, et al.
Publicado: (2019)

Cardiovascular risk of sitagliptin in treating patients with type 2 diabetes mellitus
por: Zeng, De-kang, et al.
Publicado: (2019)

Effects of sitagliptin beyond glycemic control: focus on quality of life
por: Sakamoto, Yoshiko, et al.
Publicado: (2013)

Comparison of the efficacy of sitagliptin and glimepiride dose‐up in Japanese patients with type 2 diabetes poorly controlled by sitagliptin and glimepiride in combination
por: Shimoda, Seiya, et al.
Publicado: (2013)

Effect of sitagliptin on tissue characteristics of the carotid wall in patients with type 2 diabetes: a post hoc sub-analysis of the sitagliptin preventive study of intima-media thickness evaluation (SPIKE)
por: Katakami, Naoto, et al.
Publicado: (2018)

Combined effect of metformin with ascorbic acid versus acetyl salicylic acid on diabetes-related cardiovascular complication; a 12-month single blind multicenter randomized control trial
por: Gillani, Syed Wasif, et al.
Publicado: (2017)

A pilot study of the efficacy of miglitol and sitagliptin for type 2diabetes with a continuous glucose monitoring system and incretin-related markers
por: Kishimoto, Miyako, et al.
Publicado: (2011)

Diagnostic value of cardiac magnetic resonance and fluorodeoxyglucose-positron emission tomography for cardiac sarcoidosis with previous myocardial infarction: A case report
por: Yasuda, Masakazu, et al.
Publicado: (2018)

Neutrophil Counts and Initial Presentation of 12 Cardiovascular Diseases: A CALIBER Cohort Study
por: Shah, Anoop Dinesh, et al.
Publicado: (2017)

Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study
por: Peeters, S. A., et al.
Publicado: (2017)

Depressive symptoms and major adverse cardiovascular events: 12-month follow-up in patients undergoing angiography
por: Dadkhah-Tirani, Heidar, et al.
Publicado: (2020)

Impact of glycemic control with sitagliptin on the 2-year progression of arterial stiffness: a sub-analysis of the PROLOGUE study
por: Tomiyama, Hirofumi, et al.
Publicado: (2016)

Efficacy of dapagliflozin versus sitagliptin on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a prospective, randomized study (DIVERSITY-CVR)
por: Fuchigami, Ayako, et al.
Publicado: (2020)

Comparison of effects of sitagliptin and voglibose on left ventricular diastolic dysfunction in patients with type 2 diabetes: results of the 3D trial
por: Oe, Hiroki, et al.
Publicado: (2015)

Association of Trajectory of Cardiovascular Health Score and Incident Cardiovascular Disease
por: Wu, Shouling, et al.
Publicado: (2019)

PERS&O (PERsistent Sitagliptin treatment & Outcomes): observational retrospective study on cardiovascular risk evolution in patients with type 2 diabetes on persistent sitagliptin treatment
por: Buonaiuto, Giulia, et al.
Publicado: (2016)

Comorbidities and cardiovascular risk factors in patients with psoriasis
por: Baeta, Isabela Guimarães Ribeiro, et al.
Publicado: (2014)

Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient Characteristics
por: Htoo, Phyo T., et al.
Publicado: (2022)

Significance of Cardiac Rehabilitation on Visit-to-Visit Variability of Blood Pressure in Patients With Cardiovascular Disease in a 12-Month Follow-Up
por: Ishida, Toshihisa, et al.
Publicado: (2017)

A pilot three-month sitagliptin treatment increases serum adiponectin level in Japanese patients with type 2 diabetes mellitus- a randomized controlled trial START-J study
por: Hibuse, Toshiyuki, et al.
Publicado: (2014)

Retrospective Analysis on the Efficacy, Safety and Treatment Failure Group of Sitagliptin for Mean 10-Month Duration
por: Kim, Won Jun, et al.
Publicado: (2011)

Progression of cardiovascular autonomic neuropathy and cardiovascular disease in type 2 diabetes
por: Yun, Jae-Seung, et al.
Publicado: (2018)

Differences in lipid metabolism between anagliptin and sitagliptin in patients with type 2 diabetes on statin therapy: a secondary analysis of the REASON trial
por: Chihara, Atsuko, et al.
Publicado: (2019)

Efficacy and safety of canagliflozin in patients with type 2 diabetes based on history of cardiovascular disease or cardiovascular risk factors: a post hoc analysis of pooled data
por: Davies, Michael J., et al.
Publicado: (2017)

Clinical significance of left atrial geometry in dilated cardiomyopathy patients: A cardiovascular magnetic resonance study
por: Yazaki, Mayu, et al.
Publicado: (2020)

Association Between Push-up Exercise Capacity and Future Cardiovascular Events Among Active Adult Men
por: Yang, Justin, et al.
Publicado: (2019)

Evaluation of cardiovascular disease risk factors in patients with mycosis fungoides()
por: Cengiz, Fatma Pelin, et al.
Publicado: (2015)

Cost-Effectiveness Analysis of Empagliflozin in Comparison to Sitagliptin and Saxagliptin Based on Cardiovascular Outcome Trials in Patients with Type 2 Diabetes and Established Cardiovascular Disease
por: Ramos, Mafalda, et al.
Publicado: (2019)

Sex-specific associations between adolescent categories of BMI with cardiovascular and non-cardiovascular mortality in midlife
por: Furer, Ariel, et al.
Publicado: (2018)

Reversibility of Cardiac Involvement in Acromegaly Patients After Surgery: 12-Month Follow-up Using Cardiovascular Magnetic Resonance
por: Guo, Xiaopeng, et al.
Publicado: (2020)

Associations of Serum Folate and Vitamin B(12) Levels With Cardiovascular Disease Mortality Among Patients With Type 2 Diabetes
por: Liu, Yujie, et al.
Publicado: (2022)

Assessment of North American Clinical Research Site Performance During the Start-up of Large Cardiovascular Clinical Trials
por: Goyal, Akash, et al.
Publicado: (2021)

Analysis of cardiovascular risk and carotid intima-media thickness in patients with psoriasis()()
por: Abrahão-Machado, Elaine Cristina Faria, et al.
Publicado: (2020)

Long-term effect of sitagliptin on endothelial function in type 2 diabetes: a sub-analysis of the PROLOGUE study
por: Maruhashi, Tatsuya, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_isgd5bh72a2fso5vn5su53qb48